Trinity Biotech welcomes Perceptive Advisors' debt-to-equity conversion proposal.

Monday, Oct 27, 2025 9:06 am ET1min read

Trinity Biotech welcomes Perceptive Advisors' intention to convert a portion of its outstanding debt into equity, potentially strengthening the company's balance sheet and enhancing financial flexibility. Perceptive Advisors is a leading life sciences investment firm and a supportive partner to Trinity Biotech. The proposal aims to support the company's growth objectives.

Comments



Add a public comment...
No comments

No comments yet